In financial market analysis updated in October 2026, monitoring dollar trading activity across public equities provides valuable visibility into institutional interest, market liquidity, and investor attention. A recent quantitative scan conducted by MarketBeat’s stock screener tool highlighted seven cannabis stocks that generated the highest dollar trading volume over a multi-day observation period leading up to October 13th, 2026. These highlighted entities represent a broad cross-section of the sector, encompassing international medical suppliers, state-licensed U.S. multi-state operators, specialized business development companies, retail distribution chains, and vaporizing hardware manufacturers.
What Changed: Screener Highlights Top Seven Volume Leaders
The stock screener tool developed by MarketBeat identified seven specific equities that recorded substantial dollar volume metrics relative to the broader sector. The seven highlighted companies are:
- Tilray Brands (TLRY)
- Glass House Brands (GLAS)
- Trulieve Cannabis (TRLV)
- Aurora Cannabis (ACB)
- SNDL Inc. (SNDL)
- Canopy Growth Corporation (CGC)
- Silver Spike Investment Corp. (SSIC)
These securities reflect varying corporate models, regulatory operational environments, and geographical strategies. The screening activity documented by reporting services such as Ticker Report underscores how trading liquidity concentrates around major commercial operators and specialized finance providers in the market.
Corporate Segment Analysis of the Highlighted Companies
Understanding the operating structure of each highlighted firm requires examining their formal business segments, headquarters, and distribution channels as detailed in official corporate filings and market summaries.
Tilray Brands (TLRY)
Headquartered in Canada, Tilray Brands maintains an extensive international distribution footprint for medical cannabis products. The company supplies pharmaceutical-grade and medical cannabis products across ten distinct international jurisdictions:
- Argentina
- Australia
- Canada
- Chile
- Croatia
- Cyprus
- The Czech Republic
- Germany
- New Zealand
- South Africa
By establishing regulatory compliance and distribution agreements across North America, South America, Europe, Africa, and Oceania, Tilray Brands operates as a global supplier within the medical cannabis landscape.
Glass House Brands (GLAS)
Headquartered in Long Beach, California, Glass House Brands operates as a vertically integrated cannabis company. Vertically integrated operations typically encompass cultivation, processing, manufacturing, brand development, and retail distribution within state-level regulatory frameworks.
Trulieve Cannabis (TRLV)
Trulieve Cannabis focuses heavily on consumer retail distribution and patient access. The company distributes its product lines directly through branded retail storefronts operating across six key U.S. states:
- Florida
- California
- Massachusetts
- Connecticut
- Pennsylvania
- West Virginia
In addition to its physical retail network, Trulieve Cannabis serves patients through direct home delivery services, providing home fulfillment capabilities to registered medical patients within eligible regulatory jurisdictions.
Aurora Cannabis (ACB)
Aurora Cannabis structures its operations across three primary business segments:
- Canadian Cannabis: Focuses on domestic adult-use and medical market channels within Canada.
- European Cannabis: Handles pharmaceutical-grade medical cannabis distribution across European regulatory markets.
- Plant Propagation: Operates agricultural production and plant genetics capabilities to support commercial cultivation pipelines.
SNDL Inc. (SNDL)
SNDL Inc. maintains a diversified operational portfolio structured across four dedicated business segments:
- Liquor Retail: Operates commercial retail storefronts dedicated to wine, beer, and spirits sales.
- Cannabis Retail: Manages retail dispensary networks for adult-use cannabis products.
- Cannabis Operations: Oversees cultivation, processing, extraction, and product manufacturing facilities.
- Investments: Deploys capital into debt and equity instruments across the broader cannabis industry landscape.
Canopy Growth Corporation (CGC)
Canopy Growth Corporation executes its multi-market strategy through three designated core operational segments:
- Canada Cannabis: Manages consumer adult-use brands and medical cannabis operations within the Canadian domestic market.
- International Markets Cannabis: Directs export, distribution, and commercial sales activities across international medical and consumer jurisdictions.
- Storz & Bickel: Manufactures and sells medically approved and consumer-grade vaporization devices originating from Germany.
Silver Spike Investment Corp. (SSIC)
Silver Spike Investment Corp. functions as a business development company (BDC) and specialty finance company. Unlike traditional plant-touching operators, Silver Spike Investment Corp. provides direct credit facilities, debt structures, and equity financing solutions to privately held cannabis companies seeking growth capital or refinancing options in a constrained capital market environment.
Financial Metrics and Data Overview
Data recorded across sector reports and market screeners published in October 2026 highlights key numerical metrics associated with market activity, capital distribution, and corporate evaluations across equity markets:
- Highlighted Companies: 7 cannabis equities selected by dollar volume screening tools.
- Percentage Change Metrics: 9% recorded in recent performance shifts.
- Capitalization and Volume Figures: $1.3 Billion, $220 Billion, and $17.39 Million across observed institutional transactions and aggregate valuation measurements.
- Unit and Trading Values: Data inputs of $38.00, $197,169.93, and 50 tracked across financial screener logs.
- Share and Volume Count Metrics: Numerical tracking reflecting 45,742 and 35,402 units across market exchange transactions.
These statistical indicators provide background tracking metrics utilized by financial research platforms such as MarketBeat, Wall Street Zen, and Zacks Research when evaluating equity trading volume and portfolio flows.
Market Context and Broad Financial Entities
The market context surrounding the October 13th, 2026 screener report involves broader equity market activities monitored by financial research firms, institutional wealth managers, and market data providers. Entities appearing in sector reporting context include investment banks, asset managers, technology firms, and specialty exchange-traded funds (ETFs):
- Market Research and News Providers: MarketBeat, Ticker Report, Wall Street Zen, Zacks Research.
- Institutional Financial Institutions: JPMorgan, Bridgewater Bancshares, Asset One Wealth Management LLC, Ashton Thomas Private Wealth LLC, Ascent Group LLC.
- Broad Market & Technology Corporations: Amazon, Texas Instruments, Flex, IonQ, Enerflex Ltd., Newmont Corporation, Weibo, LXP Industrial Trust.
- Specialty Investment Vehicles & Funds: Invesco BulletShares 2027 High Yield Corporate Bond ETF, SPDR Portfolio Emerging Markets ETF.
- Individual Market Researchers: Joseph Griffin.
The interactions among market infrastructure, institutional wealth managers, and specialized retail trading platforms form the broader liquidity framework in which high-volume cannabis equities operate.
Risks and Market Limitations
Investing in or evaluating public equities within the cannabis sector requires a formal understanding of structural industry risks. As documented in financial disclosure reports and market risk analyses:
- Regulatory Uncertainty: Cannabis remains subject to evolving, complex, and sometimes conflicting federal, state, and international regulatory frameworks. Federal regulations in jurisdictions such as the United States may differ significantly from state-level legalizations.
- Market Volatility: Equities in the cannabis sector frequently experience high price volatility driven by shifting legislative timelines, regulatory announcements, earnings reports, and shifting institutional capital flows.
- Varying Jurisdictional Laws: Companies operating across multiple states or international borders must navigate disparate legal regimes, tax regulations (such as section restrictions), import/export controls, and banking limitations.
- Ownership Risks: Equity ownership in cannabis businesses carries elevated risks directly linked to legal compliance, potential law enforcement shifts, access to commercial banking services, and capital availability.
Sector Implications and What to Watch Next
The inclusion of diverse operational models—ranging from Canadian licensed producers (Tilray Brands, Canopy Growth, Aurora Cannabis) and U.S. multi-state operators (Trulieve Cannabis, Glass House Brands) to retail conglomerates (SNDL Inc.) and specialty finance providers (Silver Spike Investment Corp.)—illustrates how market participants differentiate between business structures.
As market coverage progresses beyond October 2026, analysts monitor key metrics including high dollar volume persistence, corporate segment execution (such as SNDL’s liquor retail performance or Canopy’s Storz & Bickel device sales), and expansion across international medical markets (such as Tilray’s operations in Germany, Australia, and South Africa).
Attribution and Sources
This market analysis relies on research facts sourced directly from market reporting data provided by Ticker Report and MarketBeat’s equity screener tools published for October 13th, 2026.